| Financial Year |
March 31 2023 |
| Monetary Funds |
1,325,236,836.02 |
| Held-for-trading Financial Assets |
143,000,000.00 |
| Notes Receivable |
58,602,531.00 |
| Accounts Receivable |
1,148,742,579.21 |
| Advances to Suppliers |
62,942,295.39 |
| Other Receivables |
284,606,833.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
433,167,842.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
94,197,559.44 |
| Other Current Assets |
91,596,219.23 |
| Total Current Assets |
3,718,524,827.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,751,062.77 |
| Long-term Equity Investment |
350,388,163.44 |
| Investment Properties |
-- |
| Fixed Assetes |
866,676,315.79 |
| Under-construction Projects |
77,945,154.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
286,407,849.09 |
| R&D expenses |
146,947,530.47 |
| Goodwill |
107,888,213.05 |
| Long-Term Deferred and Prepaid Expenses |
82,472,739.78 |
| Deferred Income Tax Assets |
151,847,183.95 |
| Other Non-Current Assets |
36,877,395.27 |
| Sub-Total of Non-Current Assets |
2,237,298,685.29 |
| Total Assets |
5,955,823,512.71 |
| Short-Term Loans |
1,815,448,051.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
330,919,700.19 |
| Accounts Payable |
838,911,427.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,906,629.79 |
| Taxes Payable |
22,220,949.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,474,850.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
141,430,254.32 |
| Other Current Liabilities |
1,488,332.84 |
| Sub-Total of Current Liabilities |
3,236,910,057.77 |
| Long-term Loans |
7,958,400.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
132,679,150.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,370,869.42 |
| Deferred Income Tax Liabilities |
5,308,952.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
232,285,326.80 |
| Total Liabilities |
3,469,195,384.57 |
| Paid-In Capital(Or Share Stock) |
662,153,834.00 |
| Capital Surplus |
1,513,588,928.83 |
| Surplus Reserve |
55,359,635.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
242,663,579.52 |
| Minority Stockholder's Interest |
56,732,467.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,429,895,660.71 |
| Owner's Equity（Stockholder's Equity） |
2,486,628,128.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,955,823,512.71 |
